US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 41.510
  • +0.380+0.92%
Close Dec 20 16:00 ET
  • 41.510
  • 0.0000.00%
Post 16:13 ET
1.99BMarket Cap-19.96P/E (TTM)

About Mirum Pharmaceuticals Company

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Company Profile

SymbolMIRM
Company NameMirum Pharmaceuticals
Listing DateJul 18, 2019
Issue Price15.00
Founded2018
CEOMr. Christopher Peetz
MarketNASDAQ
Employees264
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 300
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-667-4085
Websitehttp://www.mirumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Peetz
  • Director and Chief Executive Officer
  • 6.45M
  • Dr. Joanne Quan, M.D.
  • Chief Medical Officer
  • --
  • Peter Radovich
  • Chief Operating Officer and President
  • 2.37M
  • Eric H. Bjerkholt
  • Chief Financial Officer
  • 4.34M
  • Dr. Pamela Vig, PhD
  • Chief Scientific Officer
  • --
  • Lara Longpre, PhD
  • Chief Development Officer
  • --
  • Michael Grey
  • Chairman of the Board
  • 451.75K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 411.75K
  • William Carl Fairey
  • Independent Director
  • 411.75K
  • Laura A. Brege
  • Independent Director
  • 426.75K
  • Timothy P. Walbert
  • Independent Director
  • 671.53K
  • Dr. Lon Cardon, PhD
  • Independent Director
  • 194.47K
  • Patrick J. Heron
  • Independent Director
  • 401.75K
  • Dr. Laurent Fischer, M.D.
  • Independent Director
  • 421.75K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List